Dr. Kevin Kjernisted

  VAN AMERINGEN M., MANCINI, C., OAKMAN, J., WALKER, J., KJERNISTED, K., CHOKKA, P., JOHNSTON, D., BENNETT, M., PATTERSON, B., (2007).  Nefazodone in the Treatment of Generalized Social Phobia:  A Randomized, Placebo-controlled Trial.  Journal of Clinical Psychiatry, 68(2):188-95.

 
  SAREEN, J., CAMPBELL, D.W.; LESLIE, W.D., MALISZA, K.L., STEIN, M.B., PAULUS, M.P., KRAVETSKY, L.B., KJERNISTED, K.D., WALKER, J.R., REISS, J.P., (2007). Striatal Function in Generalized Social Phobia: A Functional Magnetic Resonance Imaging Study.  Biol Psychiatry, 61(3):396-404.

 
  FOA, E.B., Liebowitz, M.R., Kozak, M.J., Davies, S., Campeas, R., Franklin, M.E.,   Huppert, J.D., Kjernisted, K., Rowan, V., Schmidt, A. B., Simpson, H.B., Tu, X., (2005). Randomized, Placebo-Controlled Trial of Exposure and Ritual Prevention, Clomipramine, and Their Combination in the Treatment of Obsessive Compulsive Disorder.  American Journal of Psychiatry, 162(1):151-161.

 
  SAREEN, J., Kirshner, A. Lander, M., Kjernisted, KD., Eleff, MK., Reiss, JP., (2004). Do Antipsychotics Ameliorate or Exacerbate Obsessive Compulsive Disorder Symptoms?  A Systematic Review.  Journal of Affective Disorders, 82(2):167-174.

 
  TORGRUD, L.J., Walker, J.R., Murray, L., Cox, B.J., Chartier, M., Kjernisted, K.D., (2004).  Deficits in perceived social support associated with generalized social phobia.  Cognitive Behaviour Therapy, 33(2):87-96.

 
  SIMPSON, H.B., Liebowitz, M.R., Foa, E.B., Kozak, M.J., Schmidt, A.B., Rowan, V., Petkova, E., Kjernisted, K., Huppert, J.D., Franklin, M.E., Davies, S.O., Campeas, R. , (2004).  Post-Treatment Effects of Exposure Therapy and Clomipramine in Obsessive-Compulsive Disorder.  Depression and Anxiety, 19(4): 225-233.

 
  KJERNISTED, K.D., Bleau, P., (2004).  Long-Term Goals in the Management of Acute and Chronic Anxiety Disorders.  Canadian Journal of Psychiatry, 49 (3 Suppl 1):51S-63S.

 
  KJERNISTED, KD., ENNS, M.W., LANDER, M. (2002). An Open-Label Clinical Trial of Nefazodone in Hypochondriasis, Psychosomatics 43, (4):290-294.

 
  SAREEN, J., CHARTIER, M., KJERNISTED, KD., STEIN, M.B., (2001).
Comorbidity of Phobic Disorders With Alcoholism in a Canadian Community Sample. Canadian Journal of Psychiatry, 46(8): 733-740.

 
  COX, B.J., ENNS, M.W., WALKER, J.R., KJERNISTED, K.D., PIDLUBNY, S.R., (2001).  Psychological Vulnerabilities in Patients with Major Depression versus Panic Disorder. Behaviour Research and Therapy, 39(5):567-573.

 
  WALKER, J.R., KJERNISTED, K.D. (2000) Fear: The Impact and Treatment of Social Phobia. Journal of Psychopharmacology, 14 (2) (Supplement 1); S13-S23.

 
  WALKER, J.R., VINCENT, N., FURER, P., COX, B.J., KJERNISTED, K.D. (1999) Treatment Preference in Hypochondriasis. Journal of Behaviour Therapy and Experimental Psychiatry, 30(4), 251-258.

 
  KATZ, L., FLEISHER, W., KJERNISTED, K.D., MILANESE, P., (1996).  A Review of the Psychobiology and Pharmacotherapy of PTSD.  Canadian Journal of Psychiatry, 41(4):233-238.

 

« Back to Research
© Copeman Neuroscience Centre 2007 Privacy Policy | Site Map | Website Design